CNMDCONMED Corporation

$50.47

The financials

CONMED Corporation by the numbers

CONMED Corporation (CNMD) reported revenue of $373M in Q4 2025 (quarter ended December 31, 2025), up 7.9% from the same quarter a year earlier. That came with a gross margin of 58% and net income of $17M (4.5% of revenue). For the full year FY2025, revenue was $1.37B (+5.2% year on year) and net income $47M. Its largest region in 2026-Q2 was United States at $52M, 34% of the disclosed total, just ahead of EMEA at 26%.

CONMED Corporation income statement, Q4 2025 against the same quarter a year earlier
Income statementQ4 2025Q4 2024Change
Revenue$373M$346M+7.9%
Gross profit$218M$198M+10%
Operating income$37M$52M−30%
Net income$17M$34M−50%
Diluted EPS$0.54$1.08−50%
Revenue by region, 2026-Q2, as reported to the SEC
GeographicRevenueShare
United States$52M34%
EMEA$40M26%
Asia Pacific$37M24%
Americasexcludingthe United States$24M16%

Business Segments

Revenue split by geographic segment, from SEC XBRL filings.

Latest period: Q2 2026Total $152.3M (+3.2%)
Asia Pacific grew +15% year on yearUnited States -0.07% year on year
  • United States$51.7MQoQ -7.7%year on year -0.07%
  • EMEA$40.3MQoQ +4.7%year on year +13%
  • Asia Pacific$36.6MQoQ +19%year on year +15%
  • Americasexcludingthe United States$23.8MQoQ +6.2%year on year +9.5%
Segment sum = 44% of reported consolidated revenue (partial disaggregation) · Latest source: 10-Q filed 2026-07-29, SEC EDGAR